The MMA Roadshow

Thursday, March 20 2014

Location: MIT

Managing mHealth App Development Under FDA Regulation

FDA recently published its final guidance on mobile medical apps, and while helpful, the guidance leads to more questions. This workshop will focus on answering those questions for app developers in or close to FDA regulated territory.

We have selected some of the world’s leading engineering universities – in the US and in the EU – to be our partners in this program. We have sought out not only the best schools, but those located in population centers near where developers are working.

We will dive deeply into the regulatory issues associated with bringing new mobile apps into the healthcare space.

To Register: 

MMA Roadshow Registration

Previous Locations include:

  • University of Illinois at Chicago
  • Johns Hopkins University
  • University of California San Diego
  • Stanford University
  • University of Texas at Austin

Agenda

Over the course of a four hour program, we will examine topics such as:

  1. How to develop mobile apps that come as close to the FDA line as possible, but don’t cross over into regulated territory.
  2. For those apps that FDA does regulate, how to figure out the appropriate classification in a system that frankly hasn’t been updated in a long time.
  3. If your app requires premarket clearance, what predicates are available and more importantly what strategies are there for showing substantial equivalence.
  4. Practical steps for developing an FDA quality system that is nuanced to fit mobile apps, and is designed to be as economical as possible.
  5. In a global economy, what are the differences between the US regulatory system and the EU system, and how can a company efficiently enter both markets?
  6. From the perspective of seasoned executives, what are the management challenges you can anticipate in mobile app development in a regulated environment?

You will hear directly from the experts, including regulatory attorneys, regulatory affairs specialists, quality system experts, European law attorneys, experienced mHealth executives and of course, the FDA.

Who Should Attend

These workshops will focus on mobile medical apps issues that will help both the novice and experienced FDA regulatory professional alike.

Contact

For questions about the MMA Roadshow, please contact:

Lisa Blackburn
lblackburn@ebglaw.com

Share MassBio

 

BioProcess

EvaluatePharma 

MassBio